Search research articles
Contact Us
Filters
Showing results (651-660 of 764) with videos related to
Page
of 77
Sort By:
Cytometry. Part B, Clinical Cytometry
|
November 14, 2015
Saturation monitoring of VX15/2503, a novel semaphorin 4D-specific antibody, in clinical trials
Terrence L Fisher, Jennifer Seils, Christine Reilly, et al.
Brain, Behavior, and Immunity
|
May 31, 2011
Reversal of imbalance between kynurenic acid and 3-hydroxykynurenine by antipsychotics in medication-naïve and medication-free schizophrenic patients
A M Myint, M J Schwarz, R Verkerk, et al.
Scientific Reports
|
June 24, 2020
Risk of sudden cardiac arrest and ventricular arrhythmia with sulfonylureas: An experience with conceptual replication in two independent populations
Neil Dhopeshwarkar, Colleen M Brensinger, Warren B Bilker, et al.
International Journal of Cardiology
|
November 27, 2016
Gastrointestinal bleeding and intracranial hemorrhage in concomitant users of warfarin and antihyperlipidemics
Charles E Leonard, Colleen M Brensinger, Warren B Bilker, et al.
Epilepsy & Behavior : E&B
|
April 12, 2005
Ketter's hypothesis of the mood effects of antiepileptic drugs coupled to the mechanism of action of topiramate and levetiracetam
G M P Roberts, H J M Majoie, L A M Leenen, et al.
Journal of Autism and Developmental Disorders
|
December 19, 2023
Psychotropic Medication Use in Children and Youth with Autism Enrolled in Medicaid
Jessica E Rast, Sha Tao, Whitney Schott, et al.
Journal of Affective Disorders
|
January 11, 2000
The effect of treatment with a new antidepressant, INN 00835, on platelet serotonin uptake in depressed patients
J P Kelly, G Nicolau, A Redmond, et al.
Journal of Affective Disorders
|
December 2, 2000
A double-blind, placebo-controlled, efficacy, safety, and pharmacokinetic study of INN 00835, a novel antidepressant peptide, in the treatment of major depression
J P Feighner, R H Ehrensing, A J Kastin, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
March 2, 2023
Channeling of New Neuropsychiatric Drugs-Impact on Safety and Effectiveness Studies
Danielle S Abraham, Thanh Phuong Pham Nguyen, Leah J Blank, et al.
Parkinsonism & Related Disorders
|
September 15, 2023
Comparative safety of antimuscarinics versus mirabegron for overactive bladder in Parkinson disease
Danielle S Abraham, Thanh Phuong Pham Nguyen, Craig W Newcomb, et al.
Page
of 77
Search research articles
Search
Showing results (651-660 of 764) with videos related to
Sort By:
Page
of 77
Cytometry. Part B, Clinical Cytometry
|
November 14, 2015
Saturation monitoring of VX15/2503, a novel semaphorin 4D-specific antibody, in clinical trials
Terrence L Fisher, Jennifer Seils, Christine Reilly, et al.
Brain, Behavior, and Immunity
|
May 31, 2011
Reversal of imbalance between kynurenic acid and 3-hydroxykynurenine by antipsychotics in medication-naïve and medication-free schizophrenic patients
A M Myint, M J Schwarz, R Verkerk, et al.
Scientific Reports
|
June 24, 2020
Risk of sudden cardiac arrest and ventricular arrhythmia with sulfonylureas: An experience with conceptual replication in two independent populations
Neil Dhopeshwarkar, Colleen M Brensinger, Warren B Bilker, et al.
International Journal of Cardiology
|
November 27, 2016
Gastrointestinal bleeding and intracranial hemorrhage in concomitant users of warfarin and antihyperlipidemics
Charles E Leonard, Colleen M Brensinger, Warren B Bilker, et al.
Epilepsy & Behavior : E&B
|
April 12, 2005
Ketter's hypothesis of the mood effects of antiepileptic drugs coupled to the mechanism of action of topiramate and levetiracetam
G M P Roberts, H J M Majoie, L A M Leenen, et al.
Journal of Autism and Developmental Disorders
|
December 19, 2023
Psychotropic Medication Use in Children and Youth with Autism Enrolled in Medicaid
Jessica E Rast, Sha Tao, Whitney Schott, et al.
Journal of Affective Disorders
|
January 11, 2000
The effect of treatment with a new antidepressant, INN 00835, on platelet serotonin uptake in depressed patients
J P Kelly, G Nicolau, A Redmond, et al.
Journal of Affective Disorders
|
December 2, 2000
A double-blind, placebo-controlled, efficacy, safety, and pharmacokinetic study of INN 00835, a novel antidepressant peptide, in the treatment of major depression
J P Feighner, R H Ehrensing, A J Kastin, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
March 2, 2023
Channeling of New Neuropsychiatric Drugs-Impact on Safety and Effectiveness Studies
Danielle S Abraham, Thanh Phuong Pham Nguyen, Leah J Blank, et al.
Parkinsonism & Related Disorders
|
September 15, 2023
Comparative safety of antimuscarinics versus mirabegron for overactive bladder in Parkinson disease
Danielle S Abraham, Thanh Phuong Pham Nguyen, Craig W Newcomb, et al.
Page
of 77